Lisata Therapeutics Inc (LSTA)

[Viperciara]

BASKING RIDGE, N.J., July 7, 2016 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select therapeutic development pipeline, announces today that the Company’s leadership will present at the following upcoming July conferences:

Business of Regenerative Medicine: How to Build a Company

Date and Time: Monday, July 11, 2016, 2:00 PM ET
Website: http://hsci.harvard.edu/event/brm_2016
Venue: Harvard Business School, Cambridge, Massachusetts
Topic: Building the Future: Advanced Therapies & Scalability
Presenter: Robert A. Preti, PhD, Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer of Caladrius; President, PCT

CIRM Bridges Meeting

Date and Time: Monday, July 18, 2016, 4:30 PM PT
Venue: Claremont Club & Spa, Berkeley, California
Topic: Succeeding for the Patient: Meeting Manufacturing Demands of Advanced Therapies
Presenter: Robert A. Preti, PhD, Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer of Caladrius; President, PCT

Regenerative Medicine Crossroad

Date and Time: Thursday, July 28, 2016, 1:50 PM JST
Website: https://firm.or.jp/rmit/archives/162
Venue: Nihonbashi Life Science Building, Tokyo, Japan
Topic: Autologous CD34 Cell Therapy for Treatment of Critical Limb Ischemia Under PMDA Agreement
Presenter: Douglas W. Losordo, MD, Senior Vice President Clinical, Medical and Regulatory Affairs and Chief Medical Officer of Caladrius